EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Platinum Meets Pyridine: Affinity Studies of Pyridinecarboxylic Acids and Nicotinamide for Platinum—Based Drugs

Beata Szefler iD, Kamil Szupryczyński, Przemysław Czeleń iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262411875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Beata Szefler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Chemistry, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Kurpińskiego 5, 85-096 Bydgoszcz, Poland. Hauptthemen laut MEDLINE: Niacinamide, Pyridines, Antineoplastic Agents, Platinum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 1978, platinum-based drugs have benefited countless cancer patients and come to form the foundation of many cancer pharmacotherapies. These drugs induce apoptosis in cancer cells by forming cross-links between nucleobases in the DNA. Our previous studies have shown that these drugs can also interact with other similar compounds whose structures resemble nucleobases. Therefore, this study analyzed the interactions of Cisplatin, Carboplatin, and Oxaliplatin with Pyridine derivatives (Nicotinic acid, Nicotinamide, Isonicotinic acid, and Picolinic acid). These values were then compared with those for Guanine and Adenine coming from DNA using spectroscopic methods and computational chemistry (B3LYP/6-31G(d,p) and MN15/def2-TZVP methods). Theoretical studies suggest cytostatic affinity, not only for nucleobases but also for Pyridine derivatives. Experimental studies have confirmed these theoretical results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NiacinamidePyridinesAntineoplastic AgentsPlatinumCisplatinOxaliplatinCarboplatinHumansPicolinic Acids

Stichwörter der Autor:innen

Density Functional Theory (DFT)Gibbs free energy change (ΔGr)UV-Vis spectroscopycisplatinplatinum-based drugspyridinevitamin B3

Substanzen

NiacinamidePyridinesCisplatinAntineoplastic AgentsOxaliplatinCarboplatinPlatinumPicolinic Acidspyridine

Autor:innen und Institutionen

  • Department of Physical Chemistry, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Kurpińskiego 5, 85-096 Bydgoszcz, Poland.
  • Doctoral School of Medical and Health Sciences, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Jagiellońska 13, 85-067 Bydgoszcz, Poland.

ORCID-Profile: Beata Szefler, Przemysław Czeleń

Zitieren

APA

Szefler, B., Szupryczyński, K., & Czeleń, P. (2025). Platinum Meets Pyridine: Affinity Studies of Pyridinecarboxylic Acids and Nicotinamide for Platinum—Based Drugs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411875

Vancouver

Szefler B, Szupryczyński K, Czeleń P. Platinum Meets Pyridine: Affinity Studies of Pyridinecarboxylic Acids and Nicotinamide for Platinum—Based Drugs. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411875

BibTeX
@article{Szefler2025,
  author = {Szefler, Beata and Szupryczyński, Kamil and Czeleń, Przemysław},
  title = {Platinum Meets Pyridine: Affinity Studies of Pyridinecarboxylic Acids and Nicotinamide for Platinum—Based Drugs},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262411875}
}
Kostenlos starten →